[{"Assets_0_Q1_USD":3938607000.0,"CommonStockSharesConverted_0_Q1_shares":173304193.0,"CommonStockSharesOutstanding_0_Q1_shares":173304193.0,"EarningsPerShareBasic_1_Q1_USD":-0.09,"NetIncomeLossConverted_1_Q1_USD":-16290000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-80443000.0,"RevenuesConverted_1_Q1_USD":302190000.0,"StockholdersEquity_0_Q1_USD":2769087000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170504"}]